Home Columns From the Chair

From the Chair

What’s Up with Magnesium in Patients With CKD?

Combination Therapy for Kidney Progression in Patients With CKD From Type 2 Diabetes

Imagine Halting Progression of Kidney Disease in Patients with Type 2 Diabetes

Prolyl hydroxylase inhibitors for Anemia Treatment in CKD Patients: What’s the Unmet Need?

Blood Pressure Standardization is the Key to Managing BP in CKD patients

CKD and the Long-COVID Syndrome

Treatment of CKD-associated Pruritus—a new FDA approved treatment

Should Incentives be Introduced for Kidney Donation?

Beauty and the Beast: Terlipressin for the Treatment of Hepatorenal Syndrom

The Dawn of a New Era in Renoprotection: SGLT2 Inhibitors and Mineralocorticoid Antagonists

Load more
Subscribe to RSS